BARTOLINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 16.315
NA - Nord America 10.049
AS - Asia 1.514
AF - Africa 71
SA - Sud America 33
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.986
Nazione #
PL - Polonia 11.344
US - Stati Uniti d'America 10.020
RU - Federazione Russa 1.618
SE - Svezia 730
IE - Irlanda 665
IT - Italia 563
UA - Ucraina 494
SG - Singapore 351
HK - Hong Kong 329
DE - Germania 327
CN - Cina 244
VN - Vietnam 241
GB - Regno Unito 238
FI - Finlandia 211
IN - India 107
KR - Corea 93
TR - Turchia 65
FR - Francia 40
JO - Giordania 40
CI - Costa d'Avorio 37
SC - Seychelles 33
CA - Canada 26
BR - Brasile 22
JP - Giappone 22
CH - Svizzera 21
BE - Belgio 20
NL - Olanda 16
PE - Perù 6
RO - Romania 6
HR - Croazia 4
LV - Lettonia 4
TW - Taiwan 4
AR - Argentina 3
ES - Italia 3
IR - Iran 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IL - Israele 2
MX - Messico 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 27.986
Città #
Warsaw 11.341
Santa Clara 1.913
Fairfield 1.091
Ashburn 817
Jacksonville 743
Dublin 665
Chandler 607
Woodbridge 505
Seattle 470
Cambridge 456
Wilmington 407
Houston 376
Singapore 243
Dong Ket 223
Hong Kong 200
Altamura 170
Ann Arbor 165
Princeton 165
Boardman 143
Lawrence 137
Boston 111
Beijing 102
Mumbai 99
San Diego 84
Seongnam 73
Medford 71
Phoenix 69
Izmir 61
Shanghai 57
Falls Church 55
Milan 53
Buffalo 45
Washington 40
Helsinki 38
Abidjan 37
Moscow 33
Florence 32
Los Angeles 27
Frankfurt Am Main 26
Kent 26
Norwalk 26
Auburn Hills 25
Hillsboro 24
West Jordan 24
New York 21
Bern 20
Brussels 20
Verona 19
Andover 18
Dearborn 18
Guangzhou 18
Tokyo 15
London 14
Yubileyny 14
Toronto 13
Philadelphia 11
Tappahannock 9
Mcallen 8
Ottawa 8
Saint Louis 8
Seoul 8
Bremen 7
Las Vegas 6
Redwood City 6
Lappeenranta 5
Lima 5
Moncalieri 5
Munich 5
Redmond 5
San Jose 5
Amsterdam 4
Easton 4
Frankfurt am Main 4
Fuzhou 4
Kilburn 4
Palermo 4
Riga 4
Sesto Fiorentino 4
Tucson 4
Acton 3
Bucharest 3
Central 3
Chicago 3
Dallas 3
Fano 3
Genoa 3
Monza 3
Pune 3
Romola 3
Salerno 3
San Martino Buon Albergo 3
Sassano 3
Turate 3
Atlanta 2
Bengaluru 2
Berlin 2
Bitonto 2
Buccinasco 2
Buenos Aires 2
Casnate Con Bernate 2
Totale 22.458
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 461
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 379
M1 receptor activation is a requirement for arecoline analgesia. 353
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 305
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 303
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 303
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 287
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 287
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 278
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 274
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 270
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 270
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 265
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 264
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 263
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 263
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 260
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 260
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 260
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 260
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 259
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 259
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 258
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 257
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 257
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 256
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 255
Prochlorperazine induces central antinociception mediated by the muscarinic system. 252
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 251
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 251
Role of intracellular calcium in acute thermal pain perception 251
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 250
Memory facilitation with atropine: a paradoxical effect 249
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 249
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 248
Effect of K+ channel modulation on mouse feeding behaviour 247
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 247
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 246
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 246
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 246
Endogenous morphine modulates acute thermonociception in mice. 246
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 246
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 245
Influence of potassium channel modulators on cognitive processes in mice 245
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 244
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 244
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 241
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 241
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 241
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 239
In vitro characterization of a novel, potent and selective M3 antagonist 238
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 238
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 238
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 237
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 237
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 237
Ryanodine receptors are involved in muscarinic antinociception in mice. 236
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 236
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 236
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 236
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 233
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 230
Local anaesthetic activity of beta-caryophyllene. 230
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 227
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 226
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 226
Caffeine induces central cholinergic analgesia. 226
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 225
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 224
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 223
Neuropathy-induced apoptosis: Protective effect of physostigmine 223
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 222
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 222
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 221
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 219
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 213
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 213
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 209
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 209
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 208
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 205
Antagonism by piracetam of baclofen antinociception 204
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 200
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 198
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 195
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 188
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 137
Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP) 136
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 134
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 132
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 132
ROLE OF MUSCARINIC RECEPTOR SUBTYPES IN CENTRAL ANTINOCICEPTION 132
Gi/o proteins: expression for direct activation enquiry 130
Role of histamine in rodent antinociception 128
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 127
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 126
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters 126
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 126
INVOLVEMENT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION IN METOCLOPRAMIDE ANALGESIA 125
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 123
Totale 23.133
Categoria #
all - tutte 57.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.911 0 0 0 0 0 533 412 673 387 306 552 48
2020/20213.911 314 407 181 489 205 474 206 337 277 550 82 389
2021/20221.296 29 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20254.608 241 684 416 892 1.815 560 0 0 0 0 0 0
Totale 28.131